The Pursuit of Innovation -- My journey in new therapeutics development

 

Dr. Larry Hsu is currently the Chairman  & CEO of AmMax Bio, Inc. AmMax Bio was founded in 2019 with primary focus on developing first-in-class and best-in-class drugs in the oncology area.

 

Prior to Lifemax, Dr. Hsu was the Co-founder and CEO of Impax Laboratories, a Nasdeq-listed specialty pharmaceutical company.  Impax’s business objective is applying its formulation, clinical development expertise and drug delivery technology to the development, manufacturing and sales/marketing of specialty generics and branded prescription drugs.  In the 18 years of its history, Impax Laboratories grew to a company with more than 1000 employees and a market cap of almost $3 billion USD.  Dr. Hsu retired from Impax in 2015.

 

Dr. Hsu received his Ph.D. degree in Pharmaceutics from the University of Michigan.  He worked at Abbott Laboratories for 15 years.  During the last four years at Abbott, Dr. Hsu was the Director of Product Development in charge of worldwide product development, process engineering, clinical supplies manufacturing, and production technical support of all dosage forms.  Dr. Hsu received his B.S. degree in Pharmacy from National Taiwan University.